Peres Jepchirchir Provisionally Suspended: EPO Finding Casts Shadow Over Sydney Marathon Win

Peres Jepchirchir is the most decorated women’s road runner of her generation. Olympic champion. World champion. Three-time world half marathon champion. Four World Marathon Major titles across four different races. She came back from a stress fracture to win Sydney by nearly four minutes and looked, frankly, untouchable.

On Friday, October 23, 2026, the Athletics Integrity Unit changed the picture entirely.

The AIU has provisionally suspended Jepchirchir after an out-of-competition sample collected in Kenya, before her TCS Sydney Marathon victory on August 30, returned an adverse analytical finding for EPO. The suspension is provisional and does not constitute a final sanction. But the implications, if the finding is upheld, would be the most significant doping case in women’s marathon history.

What the AIU Has Confirmed — and What It Has Not

The AIU statement is deliberately narrow. The body confirmed it has provisionally suspended Jepchirchir after an out-of-competition sample collected in Kenya, before her Sydney Marathon victory, returned an adverse analytical finding for EPO. That is the full extent of what has been officially confirmed.

The AIU has not disclosed when the sample was taken, only that it predates the August 30 race. It has not confirmed whether Jepchirchir has requested analysis of the B sample, nor have formal charges been laid. A provisional suspension means the case is under investigation. It does not mean guilt has been established and it carries no presumption of an outcome.

Jepchirchir herself has not commented publicly. The TCS Sydney Marathon issued a statement saying she is entitled to due process and that the race would make no further comment until the process concludes. The organisers acknowledged the finding and reaffirmed their partnership with the AIU on out-of-competition testing.

What a Career This Puts at Risk

The scale of what is potentially at stake here is hard to overstate. Jepchirchir is not a peripheral figure in women’s marathon running. She is arguably the central one of the past five years.

She came into Sydney having not finished a marathon since the Paris Olympics in August 2024, where she placed 15th. A stress fracture ended her spring in 2025 and she missed the London Marathon altogether. Sydney was her comeback. She won it by 3 minutes 40 seconds over compatriot Irine Cheptai, looking every bit the athlete she has always been.

Chicago, Berlin and Tokyo are the only three World Marathon Majors she has not won. She holds the women’s-only marathon world record from London 2024. She held the women’s-only half marathon world record until it was broken in September 2026. In any other week, her record stands as one of the greatest in the history of the distance.

What EPO Is and What a Ban Could Mean for Jepchirchir’s Career

EPO, or erythropoietin, is a hormone that stimulates the production of red blood cells. More red blood cells means more oxygen delivered to muscles during sustained aerobic effort. For distance runners, that is a direct performance advantage. WADA classifies EPO as a non-specified prohibited substance, the highest-severity category, reflecting that it has no legitimate therapeutic application that would explain its presence in a competitive athlete.

Under WADA rules, a first EPO offence carries a standard four-year ban. That period can be reduced if an athlete demonstrates the violation was not intentional, but EPO is not a substance typically associated with accidental ingestion. A four-year ban would effectively end Jepchirchir’s competitive career. She is 33. She would be 37 before she was eligible to compete again.

Sydney Marathon Has a Doping Problem That Predates This Case

Jepchirchir is not the first Sydney Marathon winner to face an EPO finding. She is the second in three years.

Brimin Misoi Kipkorir, who won the men’s race at the 2024 Sydney Marathon in a course record of 2:06:18, was provisionally suspended by the AIU in February 2025 after testing positive for EPO and furosemide in an out-of-competition sample collected on November 22, 2024. Furosemide is a diuretic known to be used as a masking agent before testing. The AIU confirmed both substances.

This is not a coincidence that should be dismissed. Sydney only joined the Abbott World Marathon Majors series in 2025. Within one year of that elevation, it has had the winners of two of its previous three editions face doping proceedings for the same prohibited substance. That pattern is now a story in its own right, separate from any individual case.

The race organisers have stressed their commitment to out-of-competition testing alongside their WMM partners. But the timing is brutal for a race still building its identity as a global Major.

Kenya’s Doping Crisis and the 2029 World Championships

The broader context here is one of the most uncomfortable conversations in distance running. More than 140 Kenyan athletes have been suspended or banned by the AIU since it was established in 2017. Kenya’s long-distance running community has produced an extraordinary number of doping cases, almost all involving EPO or biological passport violations.

Some recent, high-profile examples confirmed by the AIU and World Athletics:

• Ruth Chepngetich — the women’s marathon world record holder — received a three-year ban in October 2025 after admitting to doping.
• Albert Korir, winner of the New York City Marathon in 2021, was handed a five-year ban in March 2026 after testing positive for a banned substance.
• Ronald Kipkoech Korir was provisionally suspended on October 14, 2026 over an Athlete Biological Passport case.

The day before the Jepchirchir announcement, the AIU handed Ethiopian athlete Ruti Aga, the 2019 Tokyo Marathon champion, a six-year ban for a methylprednisolone positive and for interfering with the doping investigation. It was a jarring 48-hour run for the sport.

Kenya was awarded the 2029 World Athletics Championships in Nairobi just weeks ago, marking the first time the flagship championships will be held in Africa. That decision has directly intensified scrutiny on how Kenya handles its anti-doping obligations. World Athletics president Sebastian Coe visited Nairobi on October 14 and acknowledged progress while making clear there was still significant work to do.

WADA chief Witold Banka conducted a three-day visit to Nairobi earlier this month and was unambiguous in what he told Kenyan officials: “Kenya proudly calls itself the Home of Champions. To remain respected and credible, it must also be clean.” The Jepchirchir case landed less than three weeks after that visit.

Barnabas Korir, the Athletics Kenya Youth Development Director and National Olympic Committee of Kenya vice president, said he was left in shock. “We are in shock, especially in the calibre of Peres Jepchirchir after a stellar career,” he said, per AFP.

Brett Clothier, head of the AIU, has previously said that increased testing in Kenya is surfacing more cases but insisted the overall doping rate is lower than five years ago. “There’s absolutely less doping today than there was five years ago. But there’s still a lot of doping in Kenya,” he told Athletics Weekly in September 2025. Whether that framing holds up after the Jepchirchir case will be tested hard in the weeks ahead.

Photo: Katie Chan / CC BY-SA 4.0